Literature DB >> 21542896

In critically ill patients the procalcitonin level can be misleading.

Jacqueline Koeze, M G Ron Hendrix, Frank A J T M van den Bergh, René M L Brouwer, Jan G Zijlstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21542896      PMCID： PMC3219389          DOI： 10.1186/cc10132

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  5 in total

Review 1.  Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Petros Kopterides; Ilias I Siempos; Iraklis Tsangaris; Argirios Tsantes; Apostolos Armaganidis
Journal:  Crit Care Med       Date:  2010-11       Impact factor: 7.598

2.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Authors:  Lila Bouadma; Charles-Edouard Luyt; Florence Tubach; Christophe Cracco; Antonio Alvarez; Carole Schwebel; Frédérique Schortgen; Sigismond Lasocki; Benoît Veber; Monique Dehoux; Maguy Bernard; Blandine Pasquet; Bernard Régnier; Christian Brun-Buisson; Jean Chastre; Michel Wolff
Journal:  Lancet       Date:  2010-01-25       Impact factor: 79.321

3.  Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study.

Authors:  Sari Karlsson; Milja Heikkinen; Ville Pettilä; Seija Alila; Sari Väisänen; Kari Pulkki; Elina Kolho; Esko Ruokonen
Journal:  Crit Care       Date:  2010-11-15       Impact factor: 9.097

4.  Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study.

Authors:  Cees van Nieuwkoop; Tobias N Bonten; Jan W van't Wout; Ed J Kuijper; Geert H Groeneveld; Martin J Becker; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Eliane M S Leyten; Jaap T van Dissel
Journal:  Crit Care       Date:  2010-11-17       Impact factor: 9.097

Review 5.  What procalcitonin brings to management of sepsis in the ICU.

Authors:  Michel Wolff; Lila Bouadma
Journal:  Crit Care       Date:  2010-12-01       Impact factor: 9.097
  5 in total
  8 in total

1.  Should procalcitonin be used as a routine biomarker of bacterial infection?

Authors:  R R Das
Journal:  Infection       Date:  2012-03-10       Impact factor: 3.553

2.  Non-culture-based methods to diagnose bloodstream infection: Does it work?

Authors:  Miha Skvarc; David Stubljar; Petra Rogina; Achim J Kaasch
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05

3.  Expression of CD64 on neutrophils can be used to predict the severity of bloodstream infection before broad range 16S rRNA PCR.

Authors:  David Stubljar; Miha Skvarc
Journal:  Folia Microbiol (Praha)       Date:  2014-09-26       Impact factor: 2.099

4.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

5.  Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).

Authors:  Matej Godnic; David Stubljar; David Stubjar; Miha Skvarc; Tomislav Jukic
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

6.  Diagnostic accuracy of presepsin (sCD14-ST) for prediction of bacterial infection in cerebrospinal fluid samples from children with suspected bacterial meningitis or ventriculitis.

Authors:  David Stubljar; Andreja Natasa Kopitar; Mojca Groselj-Grenc; Kristina Suhadolc; Teja Fabjan; Miha Skvarc
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

7.  Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment.

Authors:  Dena El-Sayed; Jonathan Grotts; William A Golgert; Alan M Sugar
Journal:  Open Forum Infect Dis       Date:  2014-08-21       Impact factor: 3.835

8.  Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?

Authors:  Nur Efe İris; Taner Yıldırmak; Habip Gedik; Funda Şimşek; Demet Aydın; Naciye Demirel; Osman Yokuş
Journal:  Turk J Haematol       Date:  2016-06-27       Impact factor: 1.831
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.